5-Amino-1MQ: Regulatory Status
Current legal and regulatory status for 5-Amino-1MQ across jurisdictions. This page reflects the most recent verified information and is updated as regulatory actions occur.
Back to 5-Amino-1MQ overviewUnited States
Compoundable (503A)
Prescription required
Compounding status: available through compounding pharmacies and research suppliers. WADA: not listed. no regulatory development program; sold as research compound
What This Means
Compoundable does not mean FDA approved.
5-Amino-1MQ is available through licensed 503A compounding pharmacies with a physician's prescription. This is a regulatory pathway, not an endorsement of efficacy for any specific indication. All use is off-label.
Reclassification is not the same as FDA approval.
Even if 5-Amino-1MQ moves to Category 1, it remains an off-label therapeutic that requires physician supervision. Category 1 means it can be compounded under section 503A — it does not confer approved-drug status.